Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of CAIV-T (FluMist) in Healthy Children
NCT00192400Phase 3Completed
- Sponsor
- MedImmune
- Start
- Mar 2002
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 3, randomised, double-blind trial of live attenuated influenza vaccine in influenza (3 arms), sponsored by MedImmune. Primary endpoint: First episode of culture-confirmed influenza illness in the first season. Started Mar 2002; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00192400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192400.